ISRCTN17962845已完成未知
Prognostic value of pre-treatment 18FDG-PET in operable breast cancer
niversitair Ziekenhuis Brussel0 个研究点目标入组 182 人开始时间: 2020年5月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 182
研究概览
简要总结
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35582655/ (added 14/06/2023) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33689151/ (added 14/06/2023)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Patients treated at the UZ Brussel
- •2. Diagnosed in the period 2002-2015
- •3. Primary breast cancer
- •4. Histologically confirmed
- •5. Operable
- •6. Pre-treatment FDG-PET or PET/CT
排除标准
- •1. Previous history of cancer
- •2. Primary sarcoma of the breast
- •3. Palliative surgery for symptom control
- •4. No histopathological confirmation of cancer
- •5. Noninvasive carcinoma
- •6. Metastatic disease demonstrated by imaging modes other than FDG-PET
研究者
相似试验
已完成
不适用
PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) ProgressingProstate CancerNCT06460454Central Hospital, Nancy, France100
已完成
不适用
Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological CancerMalignant Neoplasm of Head and NeckLocally Advanced Malignant NeoplasmNCT02469922Center Eugene Marquis130
已完成
不适用
Evaluation of early prediction using 18F-FDG PET/CT for patients with Iodine-131 refractory differentiated thyroid carcinoma treated with lenvatinibdifferentiated thyroid carcinomaJPRN-UMIN000022592Department of Medical Oncology, Hokkaido University Graduate School of Medicine22
撤回
2 期
Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by SurgeryStage IIIA Non-Small Cell Lung CancerNCT02607423ECOG-ACRIN Cancer Research Group
招募中
不适用
The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant MelanomaMelanomaNCT05645484Wuhan Union Hospital, China100